Double Marker & Triple Marker Test in India: Purpose, Cost & What Results Mean
The double marker test and triple marker test are prenatal blood screening tests done during pregnancy in India to assess the risk of chromosomal conditions in the fetus, most importantly Down syndrome (trisomy 21), trisomy 18 (Edwards syndrome), and neural tube defects. These tests do not diagnose a condition — they calculate a statistical risk that helps parents and doctors decide whether further diagnostic testing is needed.
What Is the Double Marker Test?
The double marker test measures two substances in the mother's blood:
- PAPP-A (Pregnancy-Associated Plasma Protein-A) — a protein produced by the placenta
- Free beta-hCG (Free beta human chorionic gonadotropin) — a hormone produced by the placenta
These two markers, combined with a measurement from the NT (nuchal translucency) ultrasound scan and the mother's age, form the First Trimester Combined Screening. This combined approach has a detection rate of approximately 85–90% for Down syndrome with a false-positive rate of about 5%.
The double marker test alone — without NT scan — has a lower detection rate (around 60–65%) and is less informative. FOGSI recommends doing the blood test alongside the NT scan for the best risk calculation.
What Is the Triple Marker Test?
The triple marker test (also called the Triple Screen or Maternal Serum Screening) measures three substances in the mother's blood:
- AFP (Alpha-Fetoprotein) — a protein made by the fetal liver
- hCG (Human Chorionic Gonadotropin) — the pregnancy hormone
- uE3 (Unconjugated Estriol) — a form of oestrogen produced by the placenta and fetal liver
Some laboratories offer a Quadruple Marker Test (Quad Screen) which adds a fourth marker: 4. Inhibin A — further improves detection rate for Down syndrome
The triple screen has a detection rate of approximately 69–75% for Down syndrome with a 5% false-positive rate. When inhibin A is added (quad screen), the detection rate improves to about 80%.
When Should Each Test Be Done?
The timing of these tests is critical. Done outside the correct gestational window, results are unreliable.
| Test | Gestational Week | What It Screens For |
|---|---|---|
| Double marker (+ NT scan) | 11 weeks to 13 weeks + 6 days | Down syndrome, trisomy 18, trisomy 13 |
| Triple marker / Quad screen | 16 to 20 weeks (optimal 16–18 weeks) | Down syndrome, trisomy 18, neural tube defects |
If both tests are done (integrated screening), the combined detection rate for Down syndrome approaches 96%.
First Trimester vs Second Trimester Screening: Which Is Better?
If given the choice, first-trimester combined screening (double marker + NT scan) is preferred because:
- Results are available earlier (11–13 weeks vs 16–20 weeks)
- If results indicate high risk, there is more time to arrange diagnostic testing (CVS, amniocentesis)
- Earlier decisions reduce emotional and physical burden compared to later-stage interventions
However, for women who book late or missed the first-trimester window, the triple/quad marker test remains valuable.
How to Prepare for the Double and Triple Marker Tests
- No fasting is required for either test
- A regular blood draw is done (typically 2–3 ml of blood)
- Accurate gestational age is critical — bring your last NT scan report or dating scan report to the lab
- Inform the laboratory of any of the following as they affect result interpretation: multiple pregnancy (twins/triplets), IVF conception, insulin-dependent diabetes, smoking history
Understanding MoM Values: What Do They Mean?
Results for marker tests are reported as MoM (Multiples of the Median) rather than absolute values. MoM compares your individual result to the median value for your gestational age and is a way of standardising across different labs and populations.
Normal range: A MoM close to 1.0 means your level is average for your gestational age.
Double Marker MoM Interpretation
| Marker | Low MoM (potential concern) | Normal | High MoM (potential concern) |
|---|---|---|---|
| PAPP-A | Below 0.5 | 0.5 – 2.0 | Above 2.0 (less clinically significant) |
| Free beta-hCG | Below 0.4 | 0.4 – 2.5 | Above 2.5 |
In Down syndrome (trisomy 21): PAPP-A is typically LOW (below 0.4 MoM) and free beta-hCG is HIGH (above 2.5 MoM).
In trisomy 18 (Edwards syndrome): Both PAPP-A and free beta-hCG are LOW.
Triple Marker MoM Interpretation
| Marker | Down Syndrome Pattern | Trisomy 18 Pattern | Neural Tube Defect Pattern |
|---|---|---|---|
| AFP | Low | Low | High |
| hCG | High | Low | Normal |
| uE3 | Low | Low | Normal |
A raised AFP (above 2.5 MoM) specifically suggests neural tube defects (such as spina bifida or anencephaly) or abdominal wall defects — not chromosomal conditions.
What Does a "Screen Positive" Result Mean?
A screen positive result does NOT mean your baby has a chromosomal condition. It means the calculated risk is above a certain threshold (commonly 1 in 250 or 1 in 300 for Down syndrome). The actual meaning is:
- Low risk (e.g., 1 in 10,000): The chance of Down syndrome is very small. No further testing routinely needed.
- Intermediate risk (1 in 1,000 to 1 in 250): Further testing options are discussed with your doctor.
- High risk (e.g., 1 in 150 or higher): Your doctor will strongly recommend diagnostic testing (amniocentesis or CVS).
Important: Many women with a "high risk" screen result go on to have completely healthy babies. Equally, a "low risk" result does not guarantee a normal chromosomal outcome — no screening test is 100% sensitive.
What Happens Next if Results Are Abnormal?
If your screening result shows high risk, your gynaecologist will refer you for diagnostic testing:
1. CVS (Chorionic Villus Sampling) — 11 to 14 weeks A tiny sample of placental tissue is taken (through the abdomen or cervix) and analysed for chromosomal abnormalities. CVS provides a definitive diagnosis (not just risk assessment) and results are available in 10–14 days. Risk of miscarriage: approximately 1%.
2. Amniocentesis — 15 weeks onwards Amniotic fluid is withdrawn using a needle through the mother's abdomen. The fetal cells in the fluid are analysed for chromosomal abnormalities. Risk of miscarriage: approximately 0.5–1%. Results available in 2–3 weeks.
3. NIPT (Non-Invasive Prenatal Testing) — from 10 weeks NIPT analyses cell-free fetal DNA in the mother's blood. It has a detection rate of over 99% for Down syndrome and is essentially non-invasive (just a blood draw). Cost in India: ₹15,000–₹25,000. NIPT is not yet standard in government hospitals but is available at private centres. A positive NIPT result should still be confirmed by CVS or amniocentesis before any decision is made.
Double and Triple Marker Test Costs in India by City (2026)
| Test | Mumbai | Delhi | Bangalore | Chennai | Hyderabad | Pune | Kolkata |
|---|---|---|---|---|---|---|---|
| Double marker | ₹2,500–₹3,500 | ₹2,000–₹3,000 | ₹2,000–₹3,500 | ₹1,800–₹3,000 | ₹1,800–₹3,000 | ₹1,800–₹3,000 | ₹1,500–₹2,800 |
| NT scan (alongside) | ₹1,800–₹3,500 | ₹1,500–₹3,000 | ₹1,800–₹3,500 | ₹1,500–₹2,800 | ₹1,500–₹3,000 | ₹1,500–₹2,800 | ₹1,200–₹2,500 |
| Triple marker | ₹2,500–₹4,000 | ₹1,800–₹3,500 | ₹2,000–₹4,000 | ₹1,800–₹3,500 | ₹1,800–₹3,500 | ₹1,800–₹3,500 | ₹1,600–₹3,000 |
| Quad marker | ₹3,000–₹5,000 | ₹2,500–₹4,500 | ₹2,500–₹4,800 | ₹2,200–₹4,200 | ₹2,200–₹4,500 | ₹2,200–₹4,200 | ₹2,000–₹3,800 |
| NIPT | ₹18,000–₹25,000 | ₹15,000–₹22,000 | ₹16,000–₹23,000 | ₹15,000–₹22,000 | ₹15,000–₹22,000 | ₹15,000–₹22,000 | ₹14,000–₹20,000 |
Combined NT scan + double marker packages at private radiology centres typically range from ₹4,000 to ₹7,000, which is more cost-effective than booking separately.
Are These Tests Available at Government Hospitals?
Double and triple marker tests are not routinely available at PHCs or CHCs in India. They are available at:
- Government medical college hospitals (AIIMS, state medical colleges)
- District hospitals in larger cities (availability varies by state)
- Private diagnostic labs and private hospitals
Women attending government antenatal clinics who need marker tests are typically referred to the nearest government medical college or private lab.
How to Store Prenatal Screening Reports
Marker test reports are an important part of your pregnancy record. They are needed:
- When consulting a fetal medicine specialist
- If you need amniocentesis or CVS
- For the obstetrician planning your delivery, especially if a chromosomal condition is confirmed
- For the neonatologist attending your delivery if a condition is known
Ayu makes this simple: Photograph and upload your marker test reports immediately after collection. Tag them with the gestational week so they are easy to locate when needed. If you consult a high-risk pregnancy specialist or change hospitals, share the complete record including all scan reports, marker tests, and blood results in one QR code scan — not a series of WhatsApp photos.
Store your pregnancy reports securely with Ayu
Frequently Asked Questions
Q: Is the double marker test compulsory during pregnancy in India?
The double marker test is not legally mandatory but is strongly recommended by FOGSI for all pregnant women in the first trimester, particularly those above age 30, those with a family history of chromosomal conditions, or those who conceived via IVF. It is an important part of first-trimester combined screening and the information it provides can guide important decisions early in pregnancy.
Q: Can I skip the double marker and do the triple marker instead?
The double marker and triple marker screen for the same conditions but at different stages of pregnancy. Double marker is done at 11–13 weeks; triple marker at 16–20 weeks. If you are still within the first-trimester window, the double marker + NT scan combination is preferred because it detects more conditions and gives earlier results. If you are past 14 weeks, do the triple/quad screen.
Q: My double marker result shows "low risk 1 in 5,000" for Down syndrome — does this mean my baby is definitely normal?
A low-risk result means the probability of Down syndrome based on your blood markers, NT scan measurement, and maternal age is very small. However, no screening test is 100% accurate. A small number of affected pregnancies will still have low-risk screening results (false negatives). If you have additional concerns, discuss NIPT with your doctor — it has a higher sensitivity.
Q: What is the NT scan and why must it be done with the double marker?
The NT (nuchal translucency) scan measures a fluid-filled space at the back of the fetal neck on ultrasound. When combined with the blood markers (double marker), the risk calculation is far more accurate than either test alone. The NT scan has a specific gestational window (11–13 weeks + 6 days) and must be done by a trained sonologist certified in NT measurement.
Q: My doctor said my PAPP-A is low — what does this mean?
A low PAPP-A (below 0.4 MoM) can indicate an increased risk of chromosomal abnormalities, but it is also associated with a higher risk of pregnancy complications such as preterm birth, pre-eclampsia, fetal growth restriction, and placental insufficiency — even when chromosomal analysis is normal. Your gynaecologist will monitor your pregnancy more closely and may recommend additional growth scans in the third trimester.
Q: Are these tests covered by health insurance in India?
Coverage varies by insurer and policy. Most comprehensive health insurance policies do cover antenatal tests when the policy includes maternity benefits. Check with your insurer whether first-trimester screening (double marker + NT scan) and second-trimester screening (triple/quad marker) are listed as covered diagnostic tests under your maternity rider.
Q: How long do the results take and where do I collect them?
Double and triple marker results are typically available within 24–48 hours from reputed labs. Many labs offer digital reports via email or SMS. The risk calculation requires your NT measurement, gestational age from ultrasound, and maternal age — ensure these are provided to the lab at the time of blood collection for an accurate report.
References
- Federation of Obstetric and Gynaecological Societies of India (FOGSI). Antenatal Care and Prenatal Screening Guidelines 2021. https://www.fogsi.org
- International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). Practice Guidelines: First-Trimester Screening. https://www.isuog.org
- National Library of Medicine. Prenatal Screening for Down Syndrome in India. https://pubmed.ncbi.nlm.nih.gov/25561877/
